Le, X., Kim, H. R., Lee, D. H., Lee, S., Lee, K. H., Han, J., Kim, Y. J., Lee, G., Kim, Y. S., Kim, J. R. (2026). A phase 2 multicenter, open-label, parallel cohort study to evaluate the efficacy, safety, and pharmacokinetic profile of ABN401 in patients with advanced solid tumors harboring c-MET dysregulation.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8641